Medicare Enrolled

Dr. Muneera Atcha

Rheumatology · Salinas, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1033 LOS PALOS DR, Salinas, CA 93901
8317572058
In practice since 2011 (14 years)
NPI: 1154611796 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Atcha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Atcha? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Atcha

Dr. Muneera Atcha is a rheumatology specialist in Salinas, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Atcha performed 618 Medicare services across 363 unique beneficiaries.

Between the years covered by Open Payments, Dr. Atcha received a total of $7,497 from 42 pharmaceutical and/or device companies across 455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Atcha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 618 Medicare services $7,497 industry payments

Medicare Practice Summary

Medicare Utilization ↗
618
Medicare services
Bottom 42% in CA for rheumatology
363
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
303 $100 $250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
108 $125 $382
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
77 $71 $167
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
67 $1 $6
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
48 $65 $176
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
15 $90 $247
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,497
Total received (2019-2024)
Avg $1,250/year across 6 years
Top 34% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
455
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,345 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$153 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,610
2023
$1,310
2022
$1,230
2021
$1,316
2020
$758
2019
$1,274

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$441
ABBVIE INC.
$399
Lilly USA, LLC
$131
Janssen Biotech, Inc.
$106
GlaxoSmithKline, LLC.
$101
Novartis Pharmaceuticals Corporation
$83
E.R. Squibb & Sons, L.L.C.
$70
Octapharma USA, Inc.
$67
Sandoz Inc.
$55
Organon Llc
$33
PFIZER INC.
$31
Ultragenyx Pharmaceutical Inc.
$25
Kiniksa Pharmaceuticals International, plc
$24
Boston Scientific Corporation
$24
Actelion Pharmaceuticals US, Inc.
$21
Top 3 companies account for 60.3% of 2024 payments
All-time payments by company (2019-2024) ›
Amgen Inc.
$1,439
AbbVie Inc.
$759
Novartis Pharmaceuticals Corporation
$722
PFIZER INC.
$675
ABBVIE INC.
$627
Janssen Biotech, Inc.
$604
GlaxoSmithKline, LLC.
$346
AbbVie, Inc.
$295
UCB, Inc.
$274
Lilly USA, LLC
$218
Mallinckrodt Enterprises LLC
$185
E.R. Squibb & Sons, L.L.C.
$173
Alexion Pharmaceuticals, Inc.
$98
Sandoz Inc.
$96
Horizon Therapeutics plc
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
JAZZ PHARMACEUTICALS INC.
$73
Octapharma USA, Inc.
$67
Radius Health, Inc.
$53
Kiniksa Pharmaceuticals, Ltd.
$52
Mylan Institutional Inc.
$50
Celltrion USA Inc.
$46
Ultragenyx Pharmaceutical Inc.
$40
AstraZeneca Pharmaceuticals LP
$38
Inspire Medical Systems, Inc.
$35
Organon LLC
$35
Organon Llc
$33
HOSPIRA, INC.
$30
Aurinia Pharma U.S., Inc.
$27
Kiniksa Pharmaceuticals International, plc
$24
Boston Scientific Corporation
$24
Bioventus LLC
$24
HARMONY BIOSCIENCES LLC
$22
GENZYME CORPORATION
$21
Actelion Pharmaceuticals US, Inc.
$21
Zyla Life Sciences, Inc.
$20
Kyowa Kirin, Inc.
$19
Resmed Corp
$17
Sobi, Inc
$16
Mallinckrodt Hospital Products Inc.
$15
Gilead Sciences, Inc.
$14
Hikma Pharmaceuticals USA
$12
Top 3 companies account for 38.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ANORO · AirFit · Arcalyst · BENLYSTA · COSENTYX · Cimzia · Crysvita · Durolane · EVENITY · Enbrel · HADLIMA · HUMIRA · HYRIMOZ · Hulio · Humira · ILARIS · INFLECTRA · INSPIRE · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · REMICADE · RENFLEXIS · REYVOW · RINVOQ · Rinvoq · SAPHNELO · SKYRIZI · SPRIX · STRENSIQ · SUNOSI · Strensiq · TALTZ · TAVNEOS · TRELEGY ELLIPTA · TREMFYA · Tymlos · Wakix · WaveWriter Alpha Prime 16 · XELJANZ · XYWAV · YUFLYMA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Salinas?
Compare rheumatologists in the Salinas area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
5
Per 100K population
1.1
County median income
$94,486
Nearest hospital
SALINAS VALLEY MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Atcha is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Atcha experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Atcha performed 303 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Atcha receive payments from pharmaceutical companies?
Yes. Dr. Atcha received a total of $7,497 from 42 companies across 455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Atcha's costs compare to other rheumatologists in Salinas?
Dr. Atcha's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Atcha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →